SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-134979"
 

Search: onr:"swepub:oai:DiVA.org:uu-134979" > A signal for an abu...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Schwan, Sofie (author)

A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • 2010-06-19
  • Springer Science and Business Media LLC,2010
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-134979
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-134979URI
  • https://doi.org/10.1007/s00228-010-0853-yDOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:121119618URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of epilepsy, neuropathic pain and generalised anxiety disorder. As a GABA analogue, there has been some concern about an abuse liability. We aimed to investigate the possible abuse liability of pregabalin. By applying a Bayesian data-mining algorithm to reports of possible drug abuse or addiction in the Swedish national register of adverse drug reactions (SWEDIS), we calculated the information component (IC) for pregabalin and reports of abuse and addiction. Out of 198 reports indicative of abuse or addiction to any drug, 16 concerned pregabalin. The IC became significantly elevated in the fourth quarter of 2008, rising to 3.99 (95% confidence interval 3.21-4.59) at the end of 2009. Based on the signal from the present study, we conclude that pregabalin is likely to be associated with an abuse potential.

Subject headings and genre

  • Pregabalin
  • Abuse
  • Addiction
  • Adverse drug reaction
  • Data-mining
  • MEDICINE
  • MEDICIN

Added entries (persons, corporate bodies, meetings, titles ...)

  • Sundström, AndersKarolinska Institutet (author)
  • Stjernberg, ElisabetUppsala universitet,Klinisk farmakologi (author)
  • Hallberg, EbbaUppsala universitet,Klinisk farmakologi (author)
  • Hallberg, PärUppsala universitet,Klinisk farmakologi(Swepub:uu)pahal677 (author)
  • Karolinska InstitutetKlinisk farmakologi (creator_code:org_t)

Related titles

  • In:European Journal of Clinical Pharmacology: Springer Science and Business Media LLC66:9, s. 947-9530031-69701432-1041

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view